Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9711812rdf:typepubmed:Citationlld:pubmed
pubmed-article:9711812lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9711812lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:9711812lifeskim:mentionsumls-concept:C0010762lld:lifeskim
pubmed-article:9711812lifeskim:mentionsumls-concept:C0004237lld:lifeskim
pubmed-article:9711812lifeskim:mentionsumls-concept:C0037136lld:lifeskim
pubmed-article:9711812lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:9711812lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:9711812pubmed:issue7lld:pubmed
pubmed-article:9711812pubmed:dateCreated1998-10-13lld:pubmed
pubmed-article:9711812pubmed:abstractText1. We examined the effect of two chloro-s-triazines (atrazine and simazine) on hepatic microsomal cytochrome P450 enzymes in rat. Rats were treated intraperitoneally with atrazine or simazine daily for 3 days with 100, 200 and 400 mumol/kg. 2. Among the P450-dependent monooxygenase activities, testosterone 2 alpha-hydroxylase (T2AH) activity in rat, which is associated with CYP2C11, was significantly decreased at all doses of atrazine and simazine. The levels relative to control activities were 59-46 and 60-32% respectively. Similarly, oestradiol 2-hydroxylase (ED2H) activity was also significantly decreased by 28-51% by atrazine and simazine at all doses. However, no change in CYP2C11 protein level by either chloro-s-triazine was observed. K(m) for T2AH was significantly increased only by simazine (200 mumol/kg), whereas the Vmax and Cl(int) for T2AH were significantly decreased by atrazine and simazine at all doses. 3. 7-Ethoxyresorufin O-deethylase (EROD), 7-methoxyresorufin O-demethylase (MROD) and 7-pentoxyresorufin O-depentylase (PROD) activities were significantly increased by 1.4-1.6-, 1.7-3.2- and 1.5-2.2-fold respectively, by both chloro-s-triazines at 200 or 400 mumol/kg. Lauric acid omega-hydroxylase (LAOH) was also increased by 1.4-fold by simazine at 200 and 400 mumol/kg. Immunoblotting showed that only simazine induces CYP1A2 and CYP4A1/2 protein expression. 4. The activities of 7-ethoxycoumarin O-deethylase (ECOD), bufuralol 1'-hydroxylase (BF1'H), chlorzoxazone 6-hydroxylase (CZ6H), testosterone 6 beta-hydroxylase (T6BH) and testosterone 7 alpha-hydroxylase (T7AH) were not affected by either chloro-s-triazine. 5. These results suggest that the pattern of changes in P450 isoforms by chloro-s-triazines differs between atrazine and simazine, that these herbicides change the constitutive and/or male specific P450 isoform(s) in rat liver, and that these changes closely relate to the toxicity of chloro-s-triazines.lld:pubmed
pubmed-article:9711812pubmed:languageenglld:pubmed
pubmed-article:9711812pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:citationSubsetIMlld:pubmed
pubmed-article:9711812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711812pubmed:statusMEDLINElld:pubmed
pubmed-article:9711812pubmed:monthJullld:pubmed
pubmed-article:9711812pubmed:issn0049-8254lld:pubmed
pubmed-article:9711812pubmed:authorpubmed-author:AndoMMlld:pubmed
pubmed-article:9711812pubmed:authorpubmed-author:NishimuraTTlld:pubmed
pubmed-article:9711812pubmed:authorpubmed-author:HaniokaNNlld:pubmed
pubmed-article:9711812pubmed:authorpubmed-author:JinnoHHlld:pubmed
pubmed-article:9711812pubmed:authorpubmed-author:Tanaka-Kagawa...lld:pubmed
pubmed-article:9711812pubmed:issnTypePrintlld:pubmed
pubmed-article:9711812pubmed:volume28lld:pubmed
pubmed-article:9711812pubmed:ownerNLMlld:pubmed
pubmed-article:9711812pubmed:authorsCompleteYlld:pubmed
pubmed-article:9711812pubmed:pagination683-98lld:pubmed
pubmed-article:9711812pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:meshHeadingpubmed-meshheading:9711812-...lld:pubmed
pubmed-article:9711812pubmed:year1998lld:pubmed
pubmed-article:9711812pubmed:articleTitleChanges in rat liver cytochrome P450 enzymes by atrazine and simazine treatment.lld:pubmed
pubmed-article:9711812pubmed:affiliationDivision of Environmental Chemistry, National Institute of Health Sciences, Tokyo, Japan.lld:pubmed
pubmed-article:9711812pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9711812pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9711812lld:pubmed